These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33421332)

  • 1. Cost-effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov-model.
    Pesonen M; Kankaanpää E; Vottonen P
    Acta Ophthalmol; 2021 Nov; 99(7):e1146-e1153. PubMed ID: 33421332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies.
    Pochopien M; Beiderbeck A; McEwan P; Zur R; Toumi M; Aballéa S
    BMC Health Serv Res; 2019 Jan; 19(1):22. PubMed ID: 30626376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of various interventions for newly diagnosed diabetic macular edema.
    Stein JD; Newman-Casey PA; Kim DD; Nwanyanwu KH; Johnson MW; Hutton DW
    Ophthalmology; 2013 Sep; 120(9):1835-42. PubMed ID: 23642372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
    Dewan V; Lambert D; Edler J; Kymes S; Apte RS
    Ophthalmology; 2012 Aug; 119(8):1679-84. PubMed ID: 22503301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial.
    Mitchell P; Annemans L; Gallagher M; Hasan R; Thomas S; Gairy K; Knudsen M; Onwordi H
    Br J Ophthalmol; 2012 May; 96(5):688-93. PubMed ID: 22399690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal steroids for macular edema in diabetes.
    Rittiphairoj T; Mir TA; Li T; Virgili G
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of treatment of diabetic macular edema.
    Pershing S; Enns EA; Matesic B; Owens DK; Goldhaber-Fiebert JD
    Ann Intern Med; 2014 Jan; 160(1):18-29. PubMed ID: 24573663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
    Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment: Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial.
    Ross EL; Hutton DW; Stein JD; Bressler NM; Jampol LM; Glassman AR;
    JAMA Ophthalmol; 2016 Aug; 134(8):888-96. PubMed ID: 27280850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up.
    Romero-Aroca P; de la Riva-Fernandez S; Valls-Mateu A; Sagarra-Alamo R; Moreno-Ribas A; Soler N; Puig D
    BMC Ophthalmol; 2016 Aug; 16():136. PubMed ID: 27491545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of prevention of cystoid macular edema after cataract surgery in diabetic patients: ESCRS PREMED study report 6.
    Simons RWP; Wielders LHP; Nuijts RMMA; Veldhuizen CA; van den Biggelaar FJHM; Winkens B; Schouten JSAG; Dirksen CD;
    J Cataract Refract Surg; 2022 May; 48(5):555-563. PubMed ID: 34417781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A cost-effectiveness study of dexamethasone implants in macular edema].
    Lozano López V; Serrano García M; Mantolán Sarmiento C; Pareja Ríos A; Losada Castillo MJ; Cordovés Dorta L; Quijada Fumero E; Virgós Aller T; Bullejos Molina M
    Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic macular edema, innovative technologies and economic impact: New opportunities for the Lombardy Region healthcare system?
    Foglia E; Ferrario L; Bandello F; Ferri C; Figini I; Franzin M; Gambaro G; Introini U; Medaglia M; Staurenghi G; Tadini P; Fomiatti A; Croce D
    Acta Ophthalmol; 2018 Jun; 96(4):e468-e474. PubMed ID: 29240298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cost-Effectiveness of Ranibizumab for the Treatment of Diabetic Macular Edema.
    Brown GC; Brown MM; Turpcu A; Rajput Y
    Ophthalmology; 2015 Jul; 122(7):1416-25. PubMed ID: 25935787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial.
    Couret C; Poinas A; Volteau C; Riche VP; Le Lez ML; Errera MH; Creuzot-Garcher C; Baillif S; Kodjikian L; Ivan C; Le Jumeau de Kergaradec LM; Chiffoleau A; Jobert A; Jaulin J; Biron L; Hervouet E; Weber M
    Trials; 2020 Feb; 21(1):159. PubMed ID: 32041669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of treating wet age-related macular degeneration at the Kuopio University Hospital in Finland based on a two-eye Markov transition model.
    Vottonen P; Kankaanpää E
    Acta Ophthalmol; 2016 Nov; 94(7):652-656. PubMed ID: 27481048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S; Rush R; Natarajan S; Gillies M
    Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema.
    Cicinelli MV; Cavalleri M; Querques L; Rabiolo A; Bandello F; Querques G
    Br J Ophthalmol; 2017 Dec; 101(12):1689-1693. PubMed ID: 28432109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical dexamethasone γ-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema.
    Ohira A; Hara K; Jóhannesson G; Tanito M; Ásgrímsdóttir GM; Lund SH; Loftsson T; Stefánsson E
    Acta Ophthalmol; 2015 Nov; 93(7):610-5. PubMed ID: 26201996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.